Key Sessions

Maria João Garcia

A New Landscape: The EU HTA Regulation Impact on Biotech and Pharma in Europe

Roche

Francesco De Rubertis

A Long-awaited Return? Preparing for and Completing an IPO – The “Second Full-time Job”

Medicxi Ventures

Jan Van de Winkel

Building a Global Biotech and Innovation Beyond Boundaries

Genmab

Julie Gilmore

Fostering Next-gen Innovation: Pharma’s Evolution in Partnering with Emerging Biotechs

Eli Lilly

Day 2 – Tuesday, 30 AprilTuesday, 30 April 2024 - GMT (Greenwich Mean Time, GMTZ)

08:00 - 09:00

REGISTRATION & BREAKFAST

Showing 3 of 3 Streams

BIOTECH LEADERS KEYNOTE PLENARY

MEDTECH LEADERS

HEALTHTECH LEADERS

09:00 - 09:10

WELCOME ADDRESS

Adam Griffiths - Portfolio Manager, LSX Leaders

09:10 - 09:50

Unlocking Customer Engagement Strategies in Biotech and Pharma: Building Stronger Relationships for Sustainable Success

Diana Placido - Chief Digital Officer, ViiV Healthcare
Andrew Binns - Head of Digital Innovation, AstraZeneca
Mira Nebbache - Global Digital Product Owner, Sanofi
Marc Sluijs - Managing Partner, DigitalHealth.Network

09:50 - 10:30

Building a Global Biotech and Innovation Beyond Boundaries

Jan Van de Winkel - CEO, Genmab
Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates

09:00 - 09:10

LSX WELCOME ADDRESS

09:10 - 09:50

Unlocking the UK's MedTech Potential: Innovation, Growth, and Partnerships

Lotus Qi - Head of MedTech, Capital Enterprise
Konrad Dobschuetz - Chief Enterprise Officer, UCL Partners & NHS
Giles Hamilton - Operating Partner, New Growth Advisors
Peter Dines - Managing Director, Mercia Ventures
Alexandra Lindsay - Investment Director, Maven Capital Partners
Bala Balagaru - External Affairs Director, Johnson & Johnson

09:50 - 10:30

From Niche to Norm: Medtech's Vision for Precision Medicine

Alexander Stanke - COO & Managing Director, Preventicus
Frank Maddux - Global Chief Medical Fresenius, Fresenius Medical Care
Ana Maria Maiques Valls - CEO, Neuroelectrics
Jaochim Reischl - Head of Innovation, Diagnostics and Precision Medicine, Danaher
Neel Patel - Co-Founder & CEO, ZiO Health

09:00 - 09:10

LSX Welcome Address

Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX

09:10 - 09:50

Bridging the Digital Divide - Healthcare's Journey to Technological Advancement

Jean-Francois Rivassou - Partner, Kurma Partners
Thomas Hummel - Head of Digital Transformation, Fresenius Kabi
Aneta Gawlowska - Global Business Development & Strategy Director, Medtronic
Alexander Stanke - COO & Managing Director, Preventicus

09:50 - 10:30

Access All Areas – How Healthtech Is Tackling The Equity Challenge

Andrew Davies - Digital Health Lead, ABHI
Priya Oberoi - Founding General Partner, Goddess Gaia Ventures
Andrew Miles - Head of Healthcare and Life Sciences, EMEA, Google Cloud, Google
Mark Davies - Chief Health Officer, IBM
Geoffrey D'Hondt - Investment Manager, Heran Partners
Anushka Patchava - Co-Founder, Wellx

10:30 - 11:10

MORNING BREAK

Showing 5 of 5 Streams

BIOTECH LEADERS - CAPITAL MARKETS & INVESTMENT

BIOTECH LEADERS - PARTNERSHIPS & DEAL MAKING

BIOTECH LEADERS - SCALING & COMMERCIALISATION

MEDTECH LEADERS

HEALTHTECH LEADERS

11:10 - 12:00

Importance of IP Due-Diligence in Deals Within the US

Gwilym Attwell - Principal, Fish & Richardson P.C.
Sven Kili - Investment Advisor, Saisei Ventures
Brian Gorman - Group General Counsel, Calliditas
Guy Donatiello - Former SVP, Intellectual Property, Endo Pharmaceuticals

12:00 - 12:50

Investing in a Sound CGT Clinical Strategy to Guarantee Funding Success

Stefanie Urlinger - CSO, Cimeio Therapeutics
Johan Liwing - CEO, XNK Therapeutics
Thomas Tan - Principal, Sound Bioventures
Erik Manting - CEO, Mendus AB
Jean-Philippe Combal - CEO, Vivet Therapetuics
Hugh Watson - CFO, LenioBio

11:10 - 11:50

Synergizing Innovation: Uniting Biotech and Pharma for Advancing AI in Healthcare

Olivia Cavlan - Chief Corporate Development & Strategy Officer, Alchemab Therapeutics
Martin Alexander Gershon - Managing Partner & CIO, Endeavor Venture Fund
Sergio Quezada - CSO, Achilles Therapeutics
Jon Hu - CEO, Pepper Bio
Ping Yeh - CEO, VOCxi Health

11:50 - 12:10

Strategies Towards Breakthrough Innovation With and At Boehringer Ingelheim

Bernd Nosse - Global Head BD&L Research Beyond Borders & Technologies, Boehringer Ingelheim
Silke Hobbie - Global Head of Business Development & Licensing, Boehringer Ingelheim

12:10 - 12:50

Fostering Next-gen Innovation: Pharma’s Evolution in Partnering with Emerging Biotechs

Julie Gilmore - VP & Global Head, Gateway Labs, Eli Lilly
Khatereh Ahmadi - Head of Search & Evaluation, BD&L Europe, MSD
Silke Hobbie - Global Head of Business Development & Licensing, Boehringer Ingelheim
Michael Anstey - Partner, Cambridge Innovation Capital

11:10 - 12:00

Empowering Emerging Biotechs: Enhancing the Path to Commercialisation

Melanie Toyne-Sewell - Managing Partner, Instinctif Partners
Martijn Negen - SVP Global Commercial Strategy & Business Development, VarmX
Piers Morgan - CFO, Pangea Bio
Francis Pang - VP Global Market Access, Orchard Therapeutics

12:00 - 12:50

Crafting Success: Building an Exceptional Executive Team in Biotech

Kristen Albright - CEO, Prokarium
Jason Mellad - Chief Executive Officer & Co-Founder, Start Codon
Rosie Rodriguez - SVP Growth, Relation Therapeutics
João Ribas - Principal, Novo Holdings
Malcom Silander - Managing Partner, Co-founder, Precision BioSearch

11:10 - 11:50

Private Equity – A Catalyst For Innovation, Expansion And Success

Beat Merz - Managing Director, New Harbor Venture Partners
Sam Gray - Managing Partner, Apposite Capital
Philip Lavin - Co-Founder, Melior Capital Management
Arnaud Vincent - Managing Director, Eurazeo

11:50 - 12:10

Driving Growth in Medtech: Navigating the Intersection of Innovation and Scale

12:10 - 12:50

Deciphering the Path to US Market Entry - What Does It Take?

Giorgio Castagneto Gissey - CEO, Keyron Medical Technology
Hubert Zajicek - CEO, Co-founder & Partner, Health Wildcatters
Chris Springate - CEO, ARC Medical
Thom Rasche - Managing Partner, Earlybird
Assaf Barnea - Managing Partner, Sanara Ventures
Sanjay Parekh - Global Strategy Business Development, Perspectum

11:10 - 12:00

Real-World Evidence and Real-World Data: The Prescription for Commercial Success

Anders Borglykke - Vice President, Real-World Science, Data Science, Novo Nordisk
Ventsislav Dobrev - Global Lead Digital Health, Ypsomed
Nicole Mather - Partner, Life Sciences & Health Data Lead, IBM
Marc Jones - CEO, Altoida

12:00 - 12:50

Remote Patient Monitoring: Redefining the Standard-of-Care & Clinical Research

Yacine Hadjiat - Digital Health Innovation, MBRU
Toby Basey-Fisher - CEO, Entia
Baudouin Hue - Partner, Karista
Sam Ewing - Global Head of Pharma Partnerships, Doccla
Andrea Zitna - Partner, Speedinvest

12:50 - 14:00

LUNCH BREAK

Showing 3 of 3 Streams

BIOTECH LEADERS AFTERNOON KEYNOTE PLENARY

MEDTECH LEADERS

HEALTHTECH LEADERS

14:00 - 15:00

A New Landscape: The EU HTA Regulation Impact on Biotech and Pharma in Europe

Maria João Garcia - Global/EU HTA Strategy Lead, Roche
Thomas Lönngren - Strategic Regulatory Advisor, NDA Group
Giorgio Lotti - Head of the R&D Pipeline and Portfolio Leadership, Rare Diseases, Chiesi
Thomas Bols - Head of Government Affairs and Patient Engagement, EMEA & APAC, PTC Therapeutics, Inc
James Ryan - HTA Policy, Simulation and Analytics, AstraZeneca
Chantal Van Gils - Advisory Board Director, Global Epidemiology & Real-World Evidence, NDA Group

15:00 - 16:00

A Long-awaited Return? Preparing for and Completing an IPO – The “Second Full-time Job”

Francesco De Rubertis - Co-founder & Partner, Medicxi Ventures
Felice Verduyn-van Weegen - Partner, EQT Life Sciences
Gregg Beloff - Co-founder and Managing Director, Danforth Advisors
Richard Kivel - CEO, Graybella Capital
Isabella Schidrich - Senior Managing Director, NASDAQ

14:00 - 14:40

Mastering Regulatory Challenges in the American Medtech Market - Essential Insights for Global Expansion

Peter Bowness - VP Regulatory Affairs Europe, MCRA
Joseph Sapiente - Vice President, MDIC, MDIC
Filip Peters - CEO, Acorai
Jon H. Hoem - CEO, Cardiac Impact

14:40 - 15:20

Developing Your Clinical Trial Strategy – Meeting Compliance

Katarina Hedbeck - CEO, Tada Group
Vanessa Vankerckhoven - CEO, Director & Co-Founder, Idevax
Maria Nyåkern - Founder & Owner, Nyakern Nexus
Dan Rose - Former CEO, LimFlow
Matt Curran - CEO, Nanoflex Robotics

15:20 - 16:00

Connecting Visionary Ideas With Real-World Impact – Bridging Fundamental Innovations With Commercialisation

Daniel Green - Principal Fellow, Entrepreneurship, Imperial College London
Omar Butt - Co-Founder, Imperial College London
Michael Lewis - Scientific Director of Innovation, NIHR
Elodie Brient-Litzler - COO & Co-Founder, AVATAR Medical
Laurens de Vries - Venture Capital Analyst, Heran Partners

14:00 - 14:40

How Is Healthtech Building A Patient-Focused NHS?

Michael Macdonnell - Global Head of Healthcare & Pharma Partnerships, Huma
Mark Davies - Chief Health Officer, IBM
Peter Hames - CEO, BigHealth
Anna Dijkstra - Innovation Director, Healthcare & Life Sciences, EMEA, Microsoft
Barnaby Pickering - Senior Writer - Medtech Insight, RHA Communications

14:40 - 15:20

From Code to Care – Digital’s Role in Crafting Next-Gen Medical Devices

Robert Lauritzen - CEO, Cerebriu
Jonas Hjortshoj - Founder & Principal, Pivot Healthtech Partners
Rudolf Vohren - CEO, Nano4Imaging
Manios Dimitrakakis - CEO, Manios Dimitrakakis, Panda Surgical
Ben Finlay - Co-Founder, Ranvier.ai

15:20 - 16:00

Investing In Cutting Edge Tech - What’s The Next Big Thing On The Horizon?

Tony Cheng-Fu Chang - Sr. Business Developer, BII
Edward Kliphuis - Partner, Sofinnova Partners
Eckhardt Weber - Managing Partner, Heal Capital
Yara Alenazi - Investor, HealthTech, MassMutual Ventures
Inga Deakin - Principal, Molten Ventures

16:00 - 16:05

CLOSE OF CONGRESS

Day 2 – Tuesday, 30 AprilTuesday, 30 April 2024 - GMT (Greenwich Mean Time, GMTZ)

Day 2 – Tuesday, 30 AprilTuesday, 30 April 2024 - GMT (Greenwich Mean Time, GMTZ)

Get the Latest Event Updates